Hu-lu-su-pian ameliorates hepatic steatosis by regulating CIDEA expression in AKT-driven MASLD mice

Rumeng Ren, Qi Wang, Dongjie Deng, Aoao Guo, Xin Chen, Yan Meng, Ying Fang, Guohua Zheng, Zhong Xu, Man Li, Junjie Hu · 2025

Read Hu-lu-su-pian ameliorates hepatic steatosis by regulating CIDEA expression in AKT-driven MASLD mice by Rumeng Ren, Qi Wang, Dongjie Deng, Aoao Guo, Xin Chen, Yan Meng, Ying Fang, Guohua Zheng, Zhong Xu, Man Li, Junjie Hu (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11825746.txt.

Description

Rumeng Ren and colleagues test a melon-derived tablet against fatty liver in mice. Their study from twenty twenty-five examines Hu-lu-su-pian, a modern traditional medicine tablet. The tablet is used clinically for liver ailments in China. How it fights metabolic fatty liver was not known.

Chemical profiling first identified the tablet main ingredients. A gene-driven mouse model created fatty liver for testing. Blood tests and liver tissue checks measured treatment effects. Gene activity scans then hunted the mechanism in liver tissue. A fat-storage gene called CIDEA sat at the centre of the effect. Adjusting that gene tracked with reduced liver fat. The work gives a molecular story for a long-used remedy.

Catalog record

CREATORRumeng Ren, Qi Wang, Dongjie Deng, Aoao Guo, Xin Chen, Yan Meng, Ying Fang, Guohua Zheng, Zhong Xu, Man Li, Junjie Hu
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE40 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11825746

Browse the full library · About the Tower of Babel